HK1139671A1 - Azabicycloalkane derivatives, preparation thereof and use thereof in therapy - Google Patents

Azabicycloalkane derivatives, preparation thereof and use thereof in therapy

Info

Publication number
HK1139671A1
HK1139671A1 HK10105729.5A HK10105729A HK1139671A1 HK 1139671 A1 HK1139671 A1 HK 1139671A1 HK 10105729 A HK10105729 A HK 10105729A HK 1139671 A1 HK1139671 A1 HK 1139671A1
Authority
HK
Hong Kong
Prior art keywords
therapy
preparation
azabicycloalkane derivatives
azabicycloalkane
derivatives
Prior art date
Application number
HK10105729.5A
Other languages
English (en)
Inventor
Ayad Omar Ben
Odile Leclerc
Alistair Lochead
Mourad Saady
Franck Slowinski
Julien Vache
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1139671(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1139671A1 publication Critical patent/HK1139671A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK10105729.5A 2007-02-09 2010-06-09 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy HK1139671A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700940A FR2912404B1 (fr) 2007-02-09 2007-02-09 Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
PCT/FR2008/000137 WO2008110699A2 (fr) 2007-02-09 2008-02-04 Dérivés d'azabicycloalkane, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
HK1139671A1 true HK1139671A1 (en) 2010-09-24

Family

ID=38523491

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105729.5A HK1139671A1 (en) 2007-02-09 2010-06-09 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy

Country Status (40)

Country Link
US (2) US8173669B2 (xx)
EP (1) EP2118104B1 (xx)
JP (1) JP5356257B2 (xx)
KR (1) KR101517629B1 (xx)
CN (1) CN101605793B (xx)
AR (1) AR065248A1 (xx)
AU (1) AU2008224785B2 (xx)
BR (1) BRPI0806969A2 (xx)
CA (1) CA2677713C (xx)
CL (1) CL2008000394A1 (xx)
CO (1) CO6220857A2 (xx)
CR (1) CR10969A (xx)
CY (1) CY1113896T1 (xx)
DK (1) DK2118104T3 (xx)
DO (1) DOP2009000186A (xx)
EA (1) EA017802B1 (xx)
EC (1) ECSP099568A (xx)
ES (1) ES2402328T3 (xx)
FR (1) FR2912404B1 (xx)
GT (1) GT200900206A (xx)
HK (1) HK1139671A1 (xx)
HN (1) HN2009001484A (xx)
HR (1) HRP20130279T1 (xx)
IL (1) IL199966A (xx)
MA (1) MA31233B1 (xx)
MX (1) MX2009008492A (xx)
MY (1) MY161067A (xx)
NI (1) NI200900157A (xx)
NZ (1) NZ578673A (xx)
PE (1) PE20081664A1 (xx)
PL (1) PL2118104T3 (xx)
PT (1) PT2118104E (xx)
SI (1) SI2118104T1 (xx)
SV (1) SV2009003347A (xx)
TN (1) TN2009000314A1 (xx)
TW (1) TWI395585B (xx)
UA (1) UA97833C2 (xx)
UY (1) UY30908A1 (xx)
WO (1) WO2008110699A2 (xx)
ZA (1) ZA200905511B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002866A1 (es) * 2006-10-04 2008-07-04 Pharmacopeia Inc Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m
RU2537390C1 (ru) * 2013-07-02 2015-01-10 Федеральное государственное унитарное предприятие "Государственный завод медицинских препаратов" Способ получения 2-экзо-[3'-(6'-хлорпиридил)]-7-азабицикло[2.2.1]-гептана
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives
CN111777593B (zh) * 2019-04-03 2024-07-23 南京天印健华医药科技有限公司 作为转染期间重排激酶抑制剂的新的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610130D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Pesticidal compounds
WO1995003306A1 (en) * 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
RU2337908C2 (ru) 2003-06-12 2008-11-10 Ново Нордиск А/С Пиридинилкарбаматы в качестве ингибиторов гормон-чувствительной липазы
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.

Also Published As

Publication number Publication date
HRP20130279T1 (hr) 2013-04-30
TWI395585B (zh) 2013-05-11
CY1113896T1 (el) 2016-07-27
US8759343B2 (en) 2014-06-24
PE20081664A1 (es) 2008-12-14
GT200900206A (es) 2011-08-18
DK2118104T3 (da) 2013-04-08
WO2008110699A2 (fr) 2008-09-18
CR10969A (es) 2009-10-23
NZ578673A (en) 2011-12-22
US8173669B2 (en) 2012-05-08
KR101517629B1 (ko) 2015-05-04
SI2118104T1 (sl) 2013-05-31
UA97833C2 (ru) 2012-03-26
EA017802B1 (ru) 2013-03-29
US20120202807A1 (en) 2012-08-09
CA2677713A1 (fr) 2008-09-18
MY161067A (en) 2017-04-14
FR2912404A1 (fr) 2008-08-15
AU2008224785A1 (en) 2008-09-18
IL199966A (en) 2014-11-30
UY30908A1 (es) 2008-09-30
CL2008000394A1 (es) 2008-06-13
KR20090106600A (ko) 2009-10-09
ES2402328T3 (es) 2013-04-30
ZA200905511B (en) 2010-10-27
EP2118104A2 (fr) 2009-11-18
ECSP099568A (es) 2009-09-29
EA200970745A1 (ru) 2010-02-26
CA2677713C (fr) 2015-11-24
BRPI0806969A2 (pt) 2014-04-08
NI200900157A (es) 2010-07-15
IL199966A0 (en) 2010-04-15
TN2009000314A1 (fr) 2010-12-31
SV2009003347A (es) 2010-02-01
CN101605793B (zh) 2013-04-24
JP2010518053A (ja) 2010-05-27
CN101605793A (zh) 2009-12-16
MA31233B1 (fr) 2010-03-01
CO6220857A2 (es) 2010-11-19
JP5356257B2 (ja) 2013-12-04
WO2008110699A3 (fr) 2009-01-15
AR065248A1 (es) 2009-05-27
PL2118104T3 (pl) 2013-05-31
AU2008224785B2 (en) 2013-03-14
TW200838519A (en) 2008-10-01
DOP2009000186A (es) 2009-09-15
MX2009008492A (es) 2009-09-28
EP2118104B1 (fr) 2013-01-02
HN2009001484A (es) 2012-01-16
PT2118104E (pt) 2013-03-25
FR2912404B1 (fr) 2009-04-10
US20100035916A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
ZA201005201B (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL207078A0 (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
IL201471A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
IL204663A0 (en) Nicotinamide derivatives, preparastion thereof and therapeutic use thereof
ZA201002307B (en) Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof
IL201450A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
SI2146991T1 (sl) Derivati triazolopiridin karboksamidov njihova priprava in njihova terapevtska uporaba
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
ZA201001085B (en) Indol-2-one derivatives disubstituted in the 3-position,preparation thereof and therapeutic use thereof
ZA201107363B (en) Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
IL207629A0 (en) Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
HK1152038A1 (en) Azetidine derivatives, their preparation and their application in therapy
HK1139671A1 (en) Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
TWI366566B (en) Tricyclic n-heteroarylcarboxamide derivatives, preparation thereof and therapeutic use thereof
IL202474A0 (en) 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EP2189451A4 (en) BENZAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATIONS IN MEDICINE
SI2421864T1 (sl) 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
GB0703450D0 (en) Tropane derivatives, processes for their preparation and their use in medicine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180204